{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:00:18Z","timestamp":1774008018827,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T00:00:00Z","timestamp":1420416000000},"content-version":"vor","delay-in-days":400,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jbo.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T09:16:39Z","timestamp":1376558199000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Anna J.","family":"Lomax","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saw","family":"Yee Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Beith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehtesham","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Broad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Sewak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chooi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Sambrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret J.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine G.","family":"Yeow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2013.08.001_bib1","unstructured":"Australian Institute of Health and Welfare, Cancer Australia & Australasian Association of Cancer Registries 2008. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Cancer Series no. 42. Cat. no. CAN 38. Canberra: AIHW."},{"key":"10.1016\/j.jbo.2013.08.001_bib2","unstructured":"Buzdar AU. Therapy-induced osteoporosis in patients with breast cancer. Breast Cancer Online (\u3008www.bco.org\u3009) 6 (10); 2003."},{"key":"10.1016\/j.jbo.2013.08.001_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10 year analysis of the ATAC trial","volume":"11","author":"Cuzick","year":"2010","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.jbo.2013.08.001_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2008.07.013","article-title":"Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis","volume":"69","author":"Hadji","year":"2009","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.jbo.2013.08.001_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230","volume":"26","author":"Eastell","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jbo.2013.08.001_bib6","unstructured":"Davis S, Sambrook P. Osteoporosis in women with breast cancer. Osteoporosis Australia (unpublished)."},{"key":"10.1016\/j.jbo.2013.08.001_bib7","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.5694\/j.1326-5377.2004.tb05908.x","article-title":"Osteoporosis: underrated, underdiagnosed and undertreated","volume":"180","author":"Nguyen","year":"2004","journal-title":"Medical Journal of Australia"},{"issue":"10","key":"10.1016\/j.jbo.2013.08.001_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results","volume":"9","author":"Genant","year":"1994","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.jbo.2013.08.001_bib9","doi-asserted-by":"crossref","unstructured":"The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialist\u2032s Group. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncology 7: 633\u2013643; 2006.","DOI":"10.1016\/S1470-2045(06)70767-7"},{"key":"10.1016\/j.jbo.2013.08.001_bib10","doi-asserted-by":"crossref","unstructured":"Brufsky AM, Harker WG, Beck JT, Bosserman L, Vogel C, Seidler C et al. Final 5-year results of z-fast trial. Cancer. doi: 10.1002\/cncr.23613; 2011.","DOI":"10.1002\/cncr.26313"},{"key":"10.1016\/j.jbo.2013.08.001_bib11","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1158\/1078-0432.CCR-07-5101","article-title":"Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer","volume":"14","author":"Lester","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.jbo.2013.08.001_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jbo.2012.06.002","article-title":"Prevention of Anastrozole induced bone loss with monthly oral ibandronate: final 5 year results from the ARIBON trial","volume":"1","author":"Lester","year":"2012","journal-title":"Journal of Bone Oncology"},{"key":"10.1016\/j.jbo.2013.08.001_bib13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ctrv.2008.03.007","article-title":"Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK expert group","volume":"34","author":"Reid","year":"2008","journal-title":"Cancer Treatment Review"},{"key":"10.1016\/j.jbo.2013.08.001_bib14","doi-asserted-by":"crossref","unstructured":"Wimalawansa SJ. Vitamin D in the new millennium. Current osteoporosis reports. DOI 10.1007\/s11914-011-0094-8; 2012.","DOI":"10.1007\/s11914-011-0094-8"},{"issue":"8","key":"10.1016\/j.jbo.2013.08.001_bib15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1289\/ehp.9937","article-title":"The high prevalence of vitamin D insufficiency across australian populations is only partly explained by season and latitude","volume":"115","author":"van der Mei","year":"2007","journal-title":"Environment Health Perspective"},{"key":"10.1016\/j.jbo.2013.08.001_bib16","doi-asserted-by":"crossref","unstructured":"Diamond TH, Eisman JA, Mason RS, Nowson CA, Pasco JA, Sambrook PN, John Wark D Working group of the Australian and New Zealand bone and mineral society, endocrine society of Australia and osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Medical Journal of Australia 182 (6):281\u2013285; 2005.","DOI":"10.5694\/j.1326-5377.2005.tb06701.x"},{"key":"10.1016\/j.jbo.2013.08.001_bib17","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/annonc\/mdq707","article-title":"The effect of exemestane, anastrozole and tamoxifen on lipid profiles in japanese postmenopausal early breast cancer patients: final results of national surgical adjuvant study BC 04, the TEAM Japan Sub-study","volume":"22","author":"Hozumi","year":"2011","journal-title":"Annual Oncology"},{"key":"10.1016\/j.jbo.2013.08.001_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/annonc\/mdn545","article-title":"Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM greek substudy","volume":"20","author":"Markopoulos","year":"2009","journal-title":"Annual Oncology"},{"key":"10.1016\/j.jbo.2013.08.001_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10549-012-2147-9","article-title":"Lipid profiles within the SABRE trial of anastrozole with and without risedronate","volume":"134","author":"Van Poznak","year":"2012","journal-title":"Breast Cancer Research Treatment"},{"issue":"2","key":"10.1016\/j.jbo.2013.08.001_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2010.05.005","article-title":"Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel","volume":"37","author":"Ortmann","year":"2011","journal-title":"Cancer Treatment Review"},{"key":"10.1016\/j.jbo.2013.08.001_bib21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2005.05.3694","article-title":"Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines","volume":"24","author":"Smith","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jbo.2013.08.001_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1200\/JCO.2009.24.5902","article-title":"Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial","volume":"28","author":"Van Poznak","year":"2010","journal-title":"Journal of Clinical Oncology"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213741300047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213741300047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:16:04Z","timestamp":1761941764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221213741300047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S221213741300047X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2013.08.001","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}